NEOGENOMICS INC — Director's Dealing 2016

Mar 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2016-03-08

Reporting Person: VAN OORT DOUGLAS M (Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-08	Common Stock	M	1000000	$0.80	Acquired	2125000	Direct
2016-03-08	Common Stock	S	290000	$7.19	Disposed	1835000	Direct
2016-03-09	Common Stock	S	160000	$6.93	Disposed	1675000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-08	StockOption (Right to Buy)	$0.80	X	1000000	Disposed	2016-03-15	Common Stock (1000000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	187500	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1.71	2017-02-14	Common Stock (800000)	800000	Direct

Footnotes

F1: Includes 125,000 shares of restricted stock that the Board of Directors approved and granted on April 15, 2014. The terms of the award call for the stock to vest on the third anniversary of the grant date as long as Mr. Van Oort is still an employee of the Company. This was disclosed in our Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on July 29, 2014.

F2: Common stock was sold on March 8, 2016 and March 9, 2016 and proceeds from the sale were used as payment of the exercise price and tax liability associated with the exercise of the 1,000,000 stock options expiring on March 15, 2016. The total shares disposed of were 450,000 shares and 550,000 were retained.

F3: Conundrum Capital Partners, LLC is a limited liability partnership 50% owned by Mr. VanOort. Mr.VanOort is a managing partner of Conundrum Capital Partners, LLC.

F4: On March 19, 2009, Mr. Van Oort was granted options to purchase 1,000,000 shares. These options are being exercised as they expire on March 15, 2016.

F5: On February 14, 2012, Mr. VanOort was granted options to purchase 800,000 shares. These shares vest equally over each of the first four anniversaries of the grant date.